Cbp recruitment of Csk into lipid rafts is critical to c-Src kinase activity and bone resorption in osteoclasts.
A tyrosine kinase, c-Src, that plays an indispensable role in ruffled border formation and bone resorption is constitutively active in osteoclasts. However, to date, the molecular mechanism underlying increased c-Src activity in osteoclasts is unknown. To address this, we first examined the expression levels and subcellular localization of Csk, a negative regulatory kinase for c-Src. We found that the expression level of Csk in osteoclasts was comparable with that of other tissues. However, in osteoclasts, Csk was hardly localized in lipid rafts, where c-Src is highly expressed. Interestingly, expression of Cbp, which recruits Csk into lipid rafts through physical interaction with Csk, was very low in osteoclasts compared with other tissues. To understand the importance of Cbp in osteoclasts, we introduced Cbp into osteoclasts using an adenovirus gene delivery system. Introduction of Cbp stimulated recruitment of Csk into lipid rafts and suppressed c-Src activity in a dose-dependent manner. Furthermore, introduction of Cbp markedly inhibited formation of actin rings and bone-resorbing activity in osteoclasts. In addition, treatment with RANKL and overexpression of TRAF6 or NFAT2 inhibited Cbp expression in the osteoclastogenic cell line RAW264.7 along with osteoclastic differentiation. NFAT2 overexpression also inhibited Cbp expression in spleen macrophages. Collectively, our results indicate that reduction in Cbp expression is responsible for maintaining high c-Src activity in osteoclasts. These findings contribute to an understanding of the unique regulatory system for c-Src in osteoclasts.
Matsubara
Takuma
T
Department Molecular and Cellular Biochemistry, Osaka University Graduate School of Dentistry, Osaka, Japan.
Ikeda
Fumiyo
F
Hata
Kenji
K
Nakanishi
Masako
M
Okada
Masato
M
Yasuda
Hisataka
H
Nishimura
Riko
R
Yoneda
Toshiyuki
T
D000199:Actins / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001862:Bone Resorption / Q000235:genetics*; D000081247:CSK Tyrosine-Protein Kinase; D002454:Cell Differentiation / Q000502:physiology; D002460:Cell Line; D006834:Hydrazines; D008264:Macrophages / Q000502:physiology; D021962:Membrane Microdomains / Q000378:metabolism*; D008565:Membrane Proteins / Q000502:physiology*; D051379:Mice; D010010:Osteoclasts / Q000378:metabolism*; D010750:Phosphoproteins / Q000502:physiology*; D011505:Protein-Tyrosine Kinases / Q000502:physiology*; D011719:Pyrazines; D011804:Quinolines; D015398:Signal Transduction / Q000502:physiology; D019061:src-Family Kinases
D000199:Actins; D006834:Hydrazines; D008565:Membrane Proteins; C498709:Pag1 protein, mouse; D010750:Phosphoproteins; D011719:Pyrazines; C504331:QU663 compound; D011804:Quinolines; D011505:Protein-Tyrosine Kinases; D000081247:CSK Tyrosine-Protein Kinase; D019061:src-Family Kinases